3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
16
Lymphoid
16
Gastrointestinal
15
Thoracic
7
Plasma cell
4
Myeloid
4
Genitourinary
4
Breast
3
Other
2
Classical hematology
2
Sarcoma
1
Other solid neoplasm
1
Head & Neck
1
Gynecologic
1
Dermatologic
1
CNS
1
Conditions
Melanoma
1486
Lymphoma, T-Cell, Cutaneous
313
Skin Neoplasms
268
Keratosis, Actinic
249
Mycosis Fungoides
224
Sezary Syndrome
216
Lymphoma, Non-Hodgkin
206
Leukemia, Lymphocytic, Chronic, B-Cell
200
Lymphoma, Large B-Cell, Diffuse
198
Lymphoma, Follicular
196
Neoplasms
194
Precursor Cell Lymphoblastic Leukemia-Lymphoma
192
Lymphoma, B-Cell, Marginal Zone
192
Lymphoma, Mantle-Cell
191
Hodgkin Disease
191
Carcinoma, Basal Cell
190
Breast Neoplasms
185
Burkitt Lymphoma
184
Lymphoma
182
Lymphoma, Large-Cell, Immunoblastic
177
Carcinoma, Non-Small-Cell Lung
150
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
140
Lymphoma, Large-Cell, Anaplastic
137
Multiple Myeloma
133
Carcinoma, Renal Cell
128
Immunoblastic Lymphadenopathy
126
Uveal Melanoma
125
Neoplasm Metastasis
120
Leukemia, Myeloid, Acute
113
Waldenstrom Macroglobulinemia
103
Interventions
bemcentinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
COVID-19
×
Dermatologic
×
Clear all
NCT06469138
2025-01-29
8479217
BerGenBio ASA
Phase 1
Completed
6 enrolled
17 charts